iir’s specialty pharmacy collaboration summit · pre-conference workshop • monday, september...

Specialty Pharmacy Collaboration Summit

September 15-17, 2014 | Omni Parker House | Boston, MA

Partner to expand distribution, increase patient adherence and improve your bottom line

www.IIRSpecialtyPharmacySummit.com @healthcarebiz #SPCS14

IIR’s

NEVER-BEFORE-HEARD CASE STUDIES Accountable Care Impact on Payer

Provider Relations from Aetna, BCBS,

Tufts Health Plan, Denver Health

Medical Plan and more!

URAC AND CPPA ACCREDITATION WORKSHOPImprove operations and enhance

compliance with URAC & CPPA

Specialty Pharmacy Accreditations.

INTRODUCING

Facilitate more face-to-face meetings

in 3 days across the specialty pharmacy

ecosystem than in your entire year!

Ray Tancredi, RPh, MBA, CSP

VP, Specialty Pharmacy Development Walgreens Co.

Gregory W. Daniel,

Managing Director, and Fellow, Engelberg Center for Health Care Reform, Brookings Institution

Robert Popovian

Senior Director, US Government RelationsPfizer Pharmaceuticals

Reed Melton

Executive Director, Center for Clinical Practices Blue Cross and Blue Shield Association

HEAR EXPERTS FORECAST GROWTH & TRENDS AS THE AFFORDABLE CARE ACT REDEFINES THE INDUSTRY

Pre-Conference Workshop • Monday, September 15, 2014

URAC AND CPPA SPECIALTY PHARMACY ACCREDITATION WORKSHOP

Main Conference Day One • Tuesday, September 16, 2014

8:15 Registration Opens & Morning Coffee

8:45 Chairperson’s Welcome & Opening Remarks

Specialty Pharmacy: Evolving to Meet Patient Needs and Healthcare Challenges

Ray Tancredi, RPh, MBA, CSP, VP, Specialty Pharmacy Development, WALGREENS CO.

9:30 The True Value of Specialty Pharmacy: A Direct Impact on Bottom Line Revenue and Profits

This session will give you a 360° perspective on the impact of specialty pharmacies on bottom line profits and costs. As the industry comes under scrutiny for unprecedented profit margins and transferring cost burdens onto patients; hear from leaders in the space as they discuss the implications of strategies used internally and the implicit bottom line benefits.

Reed Melton, Executive Director, Center for Clinical Practices, BLUE CROSS AND BLUE SHIELD ASSOCIATION

Bhavesh Shah RPh, BCOP, Hematology/Oncolgoy Pharmacy Manager, BOSTON MEDICAL CENTER

10:15 Specialty Pharmacy Management in Commercial Health Plans

PAYERPANEL

This payer panel discussion will shed light on commercial plan strategies and priorities as collaboration with specialty pharmacies and pharma becomes integral to their success.

• What are payers’ top specialty pharmacy priorities and management goals?

• How does payer management intensity vary by therapeutic category?

• How does payer focus on cost management versus clinical management vary by specialty category?

Michelle Beozzo, PharmD, Director of Pharmacy Services, Managed Care, DENvER HEALTH MEDICAL PLAN

@healthcarebiz #SPCS14

URAC Accreditation 9:00 Workshop Starts

10:00 Morning Networking Break

URAC’s Specialty Pharmacy Accreditation provides an external validation of excellence in Specialty Pharmacy Management and provides Continuous Quality Improvement (CQI) oriented processes that improve operations and enhance compliance. It also helps to assist in preparing for regulatory compliance.

Key Takeaways:

• Learn how accreditation creates a pathway by which a pharmacy can build specialty pharmacy capabilities

• Develop a patient-centered specialty drug management approach

• Learn how to improve processes and procedures, promoting operational efficiencies while ensuring the highest level of customer service for a specialty pharmacy

• Understand how to build your specialty pharmacy business on quality benchmarks and performance outcome measures

Janice Anderson, Director Pharmacy Programs, URAC

10:30 Workshop continues

12:00 Workshop continues Networking Lunch

Center For Pharmacy Practice Accreditation

1:00 Meet the New Accreditor: Center for Pharmacy Practice Accreditation® (CPPA®)

The Center for Pharmacy Practice Accreditation® (CPPA®) is a partnership established by the American Pharmacists Association (APhA), the National Association of Boards of Pharmacy (NABP), and the American Society of Health-System Pharmacists (ASHP) to provide accreditation for pharmacy practice sites. CPPA® accredits those pharmacy practices that deliver high quality, safe and efficient patient care services.

Presentation Highlights:

• What makes CPPA® unique in the specialty pharmacy

accreditation market

• The four primary areas of specialty pharmacy practice (standard domains) which encompass the overall provision of care. The presentation will review the o Standards development process o The accreditation standards o The metrics and reports required for accreditation

Lynnae M Mahaney, BSPharm, MBA, FASHP, Executive Director, CPPA®

Terri Smith Moore, PhD, MBA, R.Ph, Consultant, MOORE ASSOCIATES

2:00 The Accreditation Experience: Duke University Medical Center

Duke University Medical Center became the first beta site to vet the CPPA® Pharmacy Practice accreditation process. Learn about their experience.

Paul Bush, PharmD, MBA, FASHP, BCPS, Chief Pharmacy Officer, DUkE UNIvERSITy HOSPITAL

3:15 Community/Specialty Pharmacy Practice Accreditations for Distribution Channel Partners

Gary Rice, Vice President, Clinical Services, DIPLOMAT

Accreditation brings value along the medication management continuum of care involving multiple pharmacy practice providers. Accreditation is a valuable asset in Diplomat’s unique delivery model of specialty pharmacy care.

4:00 Specialty Pharmacy Practice Accreditation and the Payer

Learn how CPPA accreditation is a differentiating factor for preferred pharmacy networks and aligns with the quality initiatives in the healthcare marketplace and payer goals.

Anthony Staresinic, Director of Pharmacy, UNITy HEALTH POINT

4:45 Wrap-Up

www.IIRSpecialtyPharmacySummit.com

Call: 888.670.8200 • Email: [email protected]

URAC AND CPPA SPECIALTY PHARMACY ACCREDITATION WORKSHOP David Brumley, MD, MBA, Senior Medical Director, TUfTS HEALTH PLAN

Pavel Lavitas, PharmD, BCPS, Clinical Consultant Pharmacist, UMASS MEDICAL SCHOOL, CLINICAL PHARMACy SERvICES

11:00 Networking Break

11:15 What Is the Value of High Cost Specialty Medicines?

KEYNOTE

Health care payment systems are evolving, where there is a greater emphasis on global payments tied to quality performance. In this session, Robert will discuss the optimal methodologies to assess the value and cost proposition of specialty medicines in the evolving payment policy environment by discussing the importance of:

• Defining quality measures for specialty medicines • Ensuring global payment models which encapsulate all

costs and outcomes including those for pharmaceuticals• Developing measures of quality and value that are relevant

to patients

Robert Popovian, Senior Director, US Government Relations, PfIzER PHARMACEUTICALS

12:00 Networking Lunch

1:00 Optimize the Patient Experience Specialty pharmacy has advanced over the years to better

meet patients’ needs receiving specialty medications as advancements in medication treatment are continually evolving and improving. The “high-touch” patient care approach goes beyond advanced care clinical models and now also includes the in-take process and gaining patient access via prior approval, appeals, and patient financial support to gain access to the medication. Key take-a-ways from the presentation includes:

• The patient journey from a new prescription, a refill, and medication compliance program examples.

• Explain the infrastructure, administrative requirements, and effective practices for managing “high-touch” patient care.

• Identify possible methods for data collecting of health outcomes in a specialty pharmacy.

Gary Rice, RPh, MS, MBA, CSP, Vice President, Clinical Services, DIPLOMAT

1:45 From Raw Data to Big Data: The Value of Data Management

As the growing specialty pharmacy niche is becoming a major force in the health care industry, the need to effectively manage ever more complex data has become a challenge. This session will run you through the importance of aggregating data and measuring outcomes for all stakeholders — patients, pharmacies, prescribers, manufacturers and insurers.

• The feasibility of transparency & stakeholder collaboration• How to manage complex data & turn it into driven

decisions

Donna Trane,VP Business Development, ACCREDO HEALTH GROUP


2:45 Under the Microscope ROUNDTABLE

Managing the cost of these extremely expensive and essential specialty drugs is key to patients. This roundtable gives you the opportunity to hone in on the specifics of each of these life threatening diseases. Hear our roundtable leaders as they shed light on their expertise with each of these disease states:

Roundtable 1: Multiple Sclerosis

Roundtable 2: Cancer

Chris Fausel, Head of Pharmacy for Oncology, IU HEALTH CANCER CENTER

Roundtable 3: Hepatitis C

Stephanie Padoan RN, BSN, MS, Director of Clinical Strategy and Development, AETNA

3:45 Impact of ACOs and Issues of Fragmentation of Care

This session will discuss:

• ACOs and their impact on specialty pharmacy• The role of academic medical centers on the effective

management of population risk and healthcare cost• Current issues with fragmentation of care• The role of integrated practice units

Kevin J. Colgan, R.Ph., MA, Director of Pharmacy, RUSH UNIvERSITy MEDICAL CENTER

4:30 Close of Conference Day One

Main Conference Day One • Tuesday, September 16, 2014

Main Conference Day Two • Wednesday, September 17, 2014

9:00 Registration Opens & Morning Coffee

9:15 Chairperson’s Recap of Day One

9:45 Embracing the Affordable Care Act for Specialty Pharmacy

Gregory W. Daniel, Managing Director and Fellow, Engelberg Center for Health Care Reform, THE BROOkINGS INSTITUTION

10:15 Changing the Channel: A Pharmaceutical Distribution Perspective

Today, specialty pharmaceuticals are special indeed: they are dominating pipelines, and their sales are forecasted to grow at twice the rate of traditional products for the next

five years, but with such rapid growth comes equally rapid change.

• What strategies can help companies sustain their commercial success?

• Develop sound distribution strategies • How to position within the channel to gain a competitive

advantage

Richard Peters, MD, PhD, Strategy Development Officer, GENzyME

Sylvia Bartel, VP Pharmacy, DANA-fARBER CANCER INSTITUTE, HARvARD UNIvERSITy


REGISTER TODAY!

© 2014 Institute for International R

esearch, Inc. All rights reserved


11:15 Has The Generic Wave and Specialty Boom Restructured the U.S. Pharmacy Industry Forever?

EXCL-USIVE

This session will open you up to a full fledged debate from industry leaders who understand the benefits of both the ‘generics wave’ and the ‘specialty boom’. This never-before-heard session discusses the strategic and tactical steps decision makers need to hop on to the bandwagon and reap the bottom line benefits.

12:00 Networking Lunch

1:00 The Specialty Pharmacy Space—Niche No More?

ROUNDTABLE

In addition to the many pharmacies that already have specialty capabilities, new sources of competition are rapidly emerging. This roundtable allows you to ‘pick your poison’ and join the discussion most relevant to you!

Roundtable 1: Independent Retail Community Pharmacies

Nick Calla, VP Industry Relations, COMMUNITy SPECIALTy PHARMACy NETWORk

Roundtable 2: Regional and National Chains Launching Specialty at Retail Programs

Christopher Benz, Business Development Director, ARMADA HEALTH CARE

Brian Burke, Vice President, National Accounts, ARMADA HEALTH CARE

Roundtable 3: Private, Independent Specialty Pharmacies

Rebecca M. Shanahan, Esq. Chief Executive Officer, AvELLA SPECIALTy PHARMACy

2:00 How Will Specialty Pharmacy Evolve in A Risk-Sharing Environment?

This session will touch on

• Specialty Therapy Management• Adherence• Cost Management

Mike Reilly, President, Pharmacy Benefit Dimensions, INDEPENDENT HEALTH

2:45 Is the SP Advantage Sustainable?

PANEL There is no one single answer to how to best manage this category of drugs, and the impact of these agents on the overall medical cost curve is still somewhat unknown. For instance, will some chronic diseases ultimately cost the system less due to the potential for specialty drugs to modify the course of a chronic disease? Or, will these potential cost savings be outweighed by a growing number of patients living longer with chronic conditions. This closing panel will discuss the:

• Challenges of effectively managing this benefit and the costs associated with it .

• What will be the impact of biosimilars?• What does the future hold?

Panelists:

Mike Reilly, President, Pharmacy Benefit Dimensions, INDEPENDENT HEALTH

3:30 Chairperson’s Closing Remarks & Close of Conference

3 Easy Ways to RegisterEASIEST! www.IIRSpecialtyPharmacySummit.com

Call: 888.670.8200 US

Email: [email protected]

Pricing & hotel

Main Conference Day Two • Wednesday, September 17, 2014

Save $600 Save $400 Save $200

Pharma, Biotech, Specialty Pharmacies, Solution Providers By 6/27/14 By 7/25/14 By 8/22/14 Standard Rate

Main Conference + Pre-Conference Workshop

$2,595 $2,795 $2,995 $3,195

Main Conference $1,795 $1,995 $2,195 $2,395

Save $400 Save $200

Health Plans By 7/25/14 By 8/22/14 Standard Rate

Main Conference + Pre-Conference Workshop

$1,595 $1,795 $1,995

Main Conference $795 $995 $1,195

SAvE 10%

Off the current rates for teams of 3-5

Off the current rates for teams of 6-8

Please contact Millison Thenor at [email protected] or 646-616-7625 to customize a registration package!

SAvE 15%

GROUPS of 9+

Team & Group Discounts

IIR’s Specialty Pharmacy Collaboration Summit is designed for teams! There is too much information available for just one person to capture it all. Plus, attendees of a conference walk away with the most value when they experience it with a peer.

For complete registration, discount, payment and cancellation policies, visit: www.IIRSpecialtyPharmacySummit.com


HOTEL Omni Parker House60 School StreetBoston, MA(617) 227-8600

Room Rate is $299/night + tax. Call 1-800-THE-OMNI; deadline is August 15, 2014 or until sold out.

REGISTER TODAY! Call: 888.670.8200 • Email: [email protected]

Dear Colleague,

Increasing health care costs backed by the reforms and changes brought about by Health Care Reforms and the ACA are a continuing challenge for all stakeholders within the health care landscape. Payers’ efforts to reduce costs and keep their premiums competitive in order to maintain profitability also put pressure on providers and patients.

Providers are facing declining reimbursement and rising costs as they work to keep their doors open, while patients are facing increased cost shares for drugs and services—particularly for high-cost specialty products. Adding to the stakeholder challenges is the continued development of highly complex, high-cost specialty therapies and the distribution of these drugs.

IIR’s Specialty Pharmacy Collaboration Summit is the only event in the industry bringing together all critical stakeholders in the specialty pharmacy value chain, including the leading pharmaceutical companies, health plans, and specialty pharmacies as the landscape develops year on year.

“By 2013, global revenue from specialty products will exceed $160 billion.” IMS Health

Join us in September as we convene to provide you with a roadmap for managing the future impact of specialty pharmacies. I look forward to seeing you there!

Kind Regards,

Sakina Hussain

Conference Director

IIR’s Specialty Pharmacy Collaboration Summit

P.S. IIR’s Specialty Pharmacy Collaboration Summit is designed to facilitate

networking, collaboration and integration between all key stakeholders

in the evolving Specialty Pharmacy value chain. Register your whole

team and save up to 15% off the current registration rates! Contact Millison

Thenor today at 646.616.7625 to develop a customized registration package

for your team!

IIR’s

NEW! INTRODUCING

Engage in pre-event discussions, view

who is attending and arrange one-to-

one meetings with partnering360®.

Foster meaningful engagement and build

relationships with key stakeholders in

the specialty pharmacy value chain to

achieve your personal objectives and your

company’s collaborative aims.

WHO SHOULD ATTEND

Pharma, Specialty Pharmacy, and Biotech: • Managed Markets

• Market Access

• Managed Care

• National Accounts

• Regional Accounts

Health Plans:• Medical Director

• VP / Director / Managers of Pharmacy

Specialty Pharmacy & PBM’s • VP / Director / Managers of Specialty

Pharmacy

• VP / Directors of Pharmacy Services

• Pharmacy Benefit Manager

BUILD RELATIONSHIPS WITH DECISION MAkERS

To learn how to sponsor or exhibit, please contact Patricia Rose at 508-614-1406 or [email protected].

MEDIA PARTNERS (AS Of 3.31.14)


Introducing

Powered by partnering360, this collaborative summit is designed to facilitate networking and integration between all key stakeholders in the evolving specialty pharmacy value chain. Efficiently meet with the right people and navigate the increasingly complex, yet essential relationship between payers, pharma manufacturers and specialty pharmacies. With partnering360, you can:

EngagE in pre and post event discussions

viEw who is attending the event

arrangE one-to-one meetings


September 15-17, 2014 | Omni Parker House | Boston, MA

Partner to expand distribution, increase patient adherence and improve your bottom line

SAVE UP TO $400 off the Standard

Registration Rates by 7/25

IIR’s



IIR’s

September 15-17, 2014Omni Parker House | Boston, MA


Institute for International Research708 Third AveNew York, NY 10017

P1968

All new!

Why Attend?Collaborate with manufacturers, insurance plans and specialty pharmacies to develop consistency and clarity around the integration of all stakeholders in the Specialty Pharmacy value chain.

Payer/Health PlansPartner for additional options to better manage your costs,patient adherence and utilization — while maintaining your bottom line.

Pharma ManufacturersGain insights into the growing Specialty Pharmacy industry, and get access to controlled or closed distribution channels for specialty drugs.

Specialty PharmaciesShowcase how your infrastructure can provide immediate insight into patient compliance, side-effect tracking, and targeted management of specialty drugs while controlling health care costs.

Route to Manager / Director:• Regional / National Accounts• Managed Markets• Pharmacy


iir’s specialty pharmacy collaboration summit · pre-conference workshop • monday, september...

Documents